Form 4: Hims & Hers Health Executive Michael Chi Reports Stock Option Exercise and Sale

Chief Commercial Officer Michael Chi of Hims & Hers Health, Inc. reports exercising stock options and selling shares under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Michael Chi, Chief Commercial Officer of Hims & Hers Health, Inc., filed a Form 4 detailing changes in beneficial ownership.
• On January 2, 2025, Chi exercised stock options to acquire 2,055 shares of Class A Common Stock at a price of $11.53 per share.
• Simultaneously, Chi sold 2,055 shares of Class A Common Stock at a price of $24.62 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Chi directly owns 193,601 shares of Class A Common Stock and holds options for 53,410 shares.
• The options vest monthly over a 4-year period, starting April 1, 2023.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing simply reports routine stock transactions under a pre-arranged plan. There is no indication of positive or negative implications for the company.

Future Outlook

NA

Industry Context

This filing is a routine disclosure of insider transactions, which are common among publicly traded companies. The use of a 10b5-1 plan suggests a proactive approach to compliance with insider trading regulations.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly listed companies, and the reporting requirements are standardized by the SEC.
• The use of a 10b5-1 trading plan is a common practice among executives to avoid accusations of insider trading, similar to practices at companies like Teladoc or GoodRx, which operate in related healthcare sectors.
• The vesting schedule of the options is typical for employee stock option plans.

Stakeholder Impact

• The transactions have a minimal direct impact on stakeholders as they are part of a pre-planned trading strategy.

Key Dates